Determining how cyclin–CDK1 complexes are regulated and function in cancer models, such as organoids derived from individuals with diseases and mouse models, and how therapeutically targeting CDK1 influences cancer progression and metastasis in these models represents an important area of future investigation. The gene discussed is CDK1; the disease is cancer.